$RTX

Bernstein Adjusts RTX Price Target to $223 From $232, Maintains Market Perform Rating

Bernstein reduced its price target for RTX from $232 to $223, while maintaining a Market Perform rating. The company's stock is currently trading at $194.60, with a 5-day change of +1.89% and a year-to-date change of -1.12%.

Original reporting
Published Sep 23, 2026, 1:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$RTX
Bearish
medium confidence
Mentioned
$RTX
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$RTXBearishMed
01

Why it matters

The downgrade suggests a near‑term price correction, but long‑term fundamentals remain intact.

02

Market read

Analyst target revisions are a common catalyst for short‑term price moves in large‑cap stocks.

03

What to watch

Recent contract wins and backlog strength are not reflected in the target change.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Bernstein's analyst team revised RTX's valuation based on updated earnings expectations and market visibility.

Company-level read

Ticker impact

$RTXBearishMedium confidence
Context

Bernstein lowered RTX's price target to $223 from $232, indicating a fresh analyst downgrade.

Expected impact

Modest decline of 1‑2% over the next few days.

Evidence & confidence

Analyst target cuts often precede price adjustments, especially when the downgrade is recent.

Market effects

Defense and aerospace sector may see slight pressure as a major player receives a lower target.

U.S. equities could experience marginal bearish bias in the defense segment.

Limited; primarily affects U.S. defense stocks.

Counterpoint

The target cut may be overly cautious; RTX's defense contracts could support upside.

Key entities

  • Raytheon Technologies

    U.S. defense and aerospace conglomerate.

  • Bernstein

    Equity research firm providing the price target adjustment.

Related articles

$LDOSMedAI 8/10

US Running Low on the 2 Weapons It Would Need Most

The US is reportedly low on air defense interceptors and long-range standoff missiles, according to a defense analyst. The Pentagon's FY 2027 budget plans to increase procurement of these weapons, benefiting companies like Leidos (NYSE:LDOS), Northrop Grumman (NYSE:NOC), Lockheed Martin (NYSE:LMT), RTX (NYSE:RTX), and L3Harris (NYSE:LHX). These companies have seen recent contract wins and revenue growth in defense-related sectors.

$LMTHigh

U.S. War Economy Updates: $33.4B Cost

Lockheed Martin (LMT) and RTX (RTX) have gained 10.3% and 6.6% YTD, while Northrop Grumman (NOC) is down 6.8%. The U.S. spent $33.4B on war efforts, including $22.3B on munitions, leading to inventory shortages. Investors may consider defense stocks amid potential increased demand due to ongoing conflicts.

$RTXMedAI 8/10

RTX Looks 23.3% Overvalued on GF Value™

RTX Corp (NYSE: RTX) secured a $105.6M contract modification for AMRAAM missile parts, funded by U.S. and international budgets. The company is trading at $190.99, 23.3% above its GF Value™ of $154.96, indicating modest overvaluation. RTX has a GF Score™ of 80/100, reflecting strong financial health but mixed insider activity.